Xcelerate Program Schedule
Wednesday, September 11
|8:55 am – 2:10 pm|
The Future of Oncology and Genetic Medicine
As groundbreaking therapies and diagnostics are coming to market, patients are benefiting from the promise of precision medicine, but many are still not able to access the latest treatments and technologies. What are hospitals and drug and diagnostic developers doing to make sure more cancer patients will go on to lead long, healthy lives? And how will precision oncology change how new drugs are developed?
By attending, you will gain deep insight from top leaders in healthcare, pharma and academia on the promises and challenges of precision cancer medicine and immunotherapies.
The headline keynote speaker is Laurie Glimcher, President and CEO of the Dana-Farber Cancer Institute, one of the world’s leading cancer research hospitals. She will discuss how far cancer diagnosis and treatment has come and where oncology and cancer research need to go.
Other Xcelerate keynote speakers — including top Harvard scientists at the cutting edge of gene therapy and CRISPR — will discuss how new approaches to correcting disease-causing mutations could transform the lives of people with genetic diseases.
Biopharma executives, scientists, researchers, investors and others from the broader life science ecosystem will learn these and other key takeaways from the forward-looking talks:
|8:55 – 9:45 am||KEYNOTE PRESENTATION|
Dana-Farber: Cancer in the 21st Century
|9:45 – 10:25 am||Networking Break – Poster Viewing and Exhibit Hall|
|10:25 – 11:00 am||KEYNOTE PRESENTATION|
Harnessing Data to Accelerate Precision Medicine
|11:00 – 11:35 am||KEYNOTE PRESENTATION|
Precision Medicine: Shaping the Future of Cancer Care
Saurabh Saha, MD, PhD
Senior Vice President R&D and Global Head of
Translational Medicine, Cambridge Site Head, Bristol-Myers Squibb
|11:35 – 1:00 pm||Lunch|
|1:00 – 1:35 pm||KEYNOTE PRESENTATION|
Decoding and Recoding AAV Therapeutic Gene Transfer
Luk Vandenberghe, PhD
Director, Grousbeck Gene Therapy Center,
Massachusetts Eye and Ear
|1:35 – 2:10 pm||KEYNOTE PRESENTATION|
Molecular Machines That Directly Correct Mutations Causing Genetic Diseases
David Liu, PhD
Co-Founder, Beam Therapeutics & Editas Medicine
Vice Chair of Faculty, Broad Institute
|2:10 – 3:45 pm||Networking Break – Poster Viewing and Exhibit Hall|
|3:45 pm – 5:15 pm|
Startup Pitch Competition
presented by EBD Group and Xconomy Insight
Four minutes, four slides. That’s what startup entrepreneurs will have to pitch their companies to a panel of judges comprising top-tier venture capitalists, pharma representatives, and private equity investors! Watch these hopefuls as they make their case.
Interested in pitching? Contact Olivia Guiliana at email@example.com or 760-692-5913.
2019 Confirmed Judges:
|5:30 pm – 9:00 pm|